Previous 10 |
home / stock / aqszf / aqszf news
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 02, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (“ Aequus” or the “ Company ”) (TSX-V: AQS) (OTCQB:AQSZF) is please...
VANCOUVER, British Columbia, April 30, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, tod...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, April 26, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (the “ Company ”) (TSX-V: AQS) (OTCQB:AQSZF) is pleased to announce that it has...
Aequus Pharmaceuticals ( OTCQB:AQSZF ): FY Net loss of $2.8M. Revenue of $1.4M (+27.3% Y/Y) Press Release More news on: Aequus Pharmaceuticals Inc., Earnings news and commentary, Consumer stocks news, ,
VANCOUVER, British Columbia, April 24, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, tod...
Aequus Pharmaceuticals ( OTCQB:AQSZF -2.3% ) announces offering of convertible debenture units at a price of $1,000 per Debenture Unit for gross proceeds of ~$3M. More news on: Aequus Pharmaceuticals Inc., Read more ...
VANCOUVER, British Columbia, April 03, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (the “ Company ”) (TSX-V: AQS) (OTCQB:AQSZF) is pleased to announce that it expects to file a preliminary prospectus supplement (the “ Prospectus Supplement ”) to its shor...
Editor's note: Seeking Alpha is proud to welcome Smart Risk Investor as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more » Aequ...
VANCOUVER, British Columbia, March 07, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”) is pleased to announce the signing of a term sheet for an exclusive license with Medicom Healthcare Ltd. (“Me...
News, Short Squeeze, Breakout and More Instantly...
Aequus Pharmaceuticals Inc Company Name:
AQSZF Stock Symbol:
OTCMKTS Market:
Aequus Pharmaceuticals Inc Website:
(TheNewswire) VANCOUVER, BC. July 3 rd – TheNewswire – Aequus Pharmaceuticals Inc. (TSX-V: AQS , OTCQB: AQSZF ), ) (“Aequus” or the “Company”), a specialty pharmaceutical company, announces...
(TheNewswire) VANCOUVER – TheNewswire - May 22, 2024 – Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company focused on bringing healthcare solutions to Canadians through licen...
(TheNewswire) VANCOUVER, May 09, 2024 – TheNewswire – Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company focused on bringing healthcare solutions to Canadians through licens...